25 min. Read
5.27.22

Who controls the Spice?

In this article:

The inside story of how Apple timed its 2018 de novos in collaboration with the FDA — thanks to its Pre-Cert Pilot Program. Following a series of FOIA requests, E&O analyzed more than 17,000 pages of emails and other documents that Apple and the FDA exchanged between 2013 and 2019 to investigate Apple’s original regulatory clearances.

In December 2015, about 18 months before he became the Commissioner of the FDA, Scott Gottlieb MD wrote a column for Forbes entitled, "Why Apple Dumbs down Your Smartphone."

Gottlieb argued that while Apple "advances the medical promise of its watch

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Approximating Omada Health’s S-1 Before Its 2025 IPO
11.22.24
21 min. Read
The Spring Health Report
8.18.23
20 min. Read
The Sword Health Report
8.02.23
21 min. Read
The Big Health Report
5.12.23
29 min. Read
The Virta Health Report
10.28.22
31 min. Read
The Noom Report
10.29.21
39 min. Read
The Crossover Health Report
4.19.21
22 min. Read
Analysis: Livongo founders’ HAAC SPAC
1.25.21
11 min. Read
The UnitedHealth Group Report
12.30.20
30 min. Read
The Virgin Pulse Report
9.25.20
14 min. Read
  • First
  • Previous
  • 1 of 2
  • Next
  • Last